Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The South Australian <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy service: an 11-year review of toxicity, health-related quality of life, and survival.

ESMO gastrointestinal oncology·2026
Same author

Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure.

Annals of clinical and translational neurology·2025
Same author

Preinterventional Third-Molar Assessment Using Robust Machine Learning.

Journal of dental research·2023
Same author

Computer-assisted bone augmentation, implant planning and placement: An in vitro investigation.

Clinical oral implants research·2023
Same author

Novel prediction models for hyperketonemia using bovine milk Fourier-transform infrared spectroscopy.

Preventive veterinary medicine·2023
Same author

Influence of pedestal diameter on mode instabilities in Yb/Ce/Al-doped fibers.

Optics express·2020

Related Experiment Video

Updated: Jun 5, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Prophylactic ASA against Myocardial Infarction: Physician Attitudes and Practices.

P McNamara, G Hardacre, D Macdiarmid

    Canadian Family Physician Medecin De Famille Canadien
    |January 14, 2011
    PubMed
    Summary

    Physicians are aware of studies on aspirin (acetylsalicylic acid) for heart attack prevention in men over 40. However, most physicians seldom or never recommend aspirin for primary prevention in this patient group.

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
    05:41

    Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

    Published on: December 16, 2022

    Area of Science:

    • Cardiology
    • Preventive Medicine
    • Clinical Practice

    Background:

    • Myocardial infarction (MI) is a leading cause of mortality in men over 40.
    • Primary prophylaxis strategies aim to reduce MI incidence in asymptomatic individuals.
    • Acetylsalicylic acid (ASA) has been investigated for its role in cardiovascular event prevention.

    Purpose of the Study:

    • To assess physician awareness and current practices regarding ASA for primary MI prophylaxis.
    • To understand physician attitudes towards recommending ASA in asymptomatic men >40 years old.

    Main Methods:

    • A survey was conducted among 172 physicians.
    • The survey focused on physician knowledge of recent ASA studies and their recommendation practices for primary MI prevention.

    Main Results:

    • 71.4% of surveyed physicians were aware of recent studies on ASA for primary MI prophylaxis.
    • Only 8.1% of physicians regularly recommended ASA for this indication.
    • A significant proportion (54.6%) seldom or never recommended ASA.

    Conclusions:

    • Physician awareness of ASA's role in primary MI prevention is high.
    • Despite awareness, the regular recommendation of ASA for primary prophylaxis in asymptomatic men over 40 remains low.
    • Clinical practice patterns may not fully align with emerging evidence for ASA use in primary cardiovascular prevention.